A work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new perspectives for the possible use of fatty acids and mitochondrial oxidative metabolism in new pharmacological approaches to decrease the metastasis of hepatocellular carcinoma.
Researchers from IDIBELL and ICO have used an orthotopic mouse model to expand the myeloma patient’s tumor tissue to study his molecular characteristics and response to different treatments.
A mouse model to predict the response to the treatment of a myeloma patient Read More »
The Tobacco Control Research Group has received one of the World No Tobacco Day 2021 Awards from the World Health Organization for their work in the field of tobacco control.
Tobacco Control Research Groups awarded by the WHO Read More »
This campaign, launched by the Catalan Network of Smoke-Free Hospitals, wants to move away tobacco from the hospital environment.
Starts the campaign “Let’s push tobacco away” Read More »
Fernando Fernández-Aranda takes over from Josep Manuel Menchón as Scientific Director. This nomination will allow continuing the IDIBELL’s promotion as a reference center in biomedical research.
Fernando Fernández Aranda, the new Scientific Director of IDIBELL Read More »
The atrophy of a specific region of the cerebral cortex is related to the appearance of apathy in Huntington’s patients, a neurodegenerative disease that affects motor and cognitive function. This is the conclusion of a study of the Bellvitge Biomedical Research Institute (IDIBELL) published in the Movement Disorders journal.
Hyperactivation of the RANK pathway plays a double function in breast cells: in the early stages of cancer, it activates senescence, which has a protective effect and delays the appearance of tumours
The date of the election to celebrate this anniversary coincides with the birth of nurse Florence Nightingale, a pioneer of modern nursing
May 12 – International Nursing Day Read More »
Research It is a rare disease that causes malformations in blood vessels. The study has discovered the implication of a protein in the development of the pathology.
Researchers identify a possible therapy against Rendu-Osler disease Read More »
